Madame Bioscience PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	109.14	170.26	80.19	34.34	252.69	41.26
Short-Term Investments	-	23.55	0.43	0.42	0.65	11.13
Cash & Short-Term Investments	109.14	193.81	80.62	34.76	253.34	52.39
Cash Growth	333.11%	140.41%	131.96%	-86.28%	383.56%	-47.52%
Accounts Receivable	218.11	130.67	284.08	293.04	261.71	310.9
Other Receivables	-	8.46	63.98	42.64	49.17	35.98
Receivables	218.11	139.13	348.06	335.68	310.87	346.87
Inventory	56.61	47.04	142.02	237.64	280.56	361.82
Prepaid Expenses	-	5.44	8.11	8.77	7.44	12.71
Other Current Assets	7.9	14.53	6.55	17.86	29.81	66.65
Total Current Assets	391.77	399.95	585.35	634.7	882.03	840.44
Property, Plant & Equipment	350.24	357.09	675.01	943.3	1,015	624.97
Goodwill	323.3	323.3	241.08	241.08	429.05	77.47
Other Intangible Assets	104.45	107.28	62.49	67.83	73.34	5.33
Long-Term Deferred Tax Assets	-	-	0.53	1.67	7.25	5.58
Other Long-Term Assets	119.58	129.3	56.83	149.98	49.89	30.96
Total Assets	1,289	1,317	1,621	2,039	2,457	1,585
Accounts Payable	211.35	134.68	282.28	242.78	185.02	209.32
Accrued Expenses	0.58	27.95	36.2	82.52	47.29	78.1
Short-Term Debt	58.92	46.43	159.79	161.75	196.61	138.19
Current Portion of Long-Term Debt	2.84	42.66	239.46	363.51	61.86	31.55
Current Portion of Leases	2.69	4.34	15.98	18.67	24.95	22.28
Current Income Taxes Payable	1.34	1.34	-	-	-	-
Other Current Liabilities	0.21	69.57	91.83	66.44	63.73	64.74
Total Current Liabilities	277.92	326.97	825.54	935.67	579.47	544.18
Long-Term Debt	142.68	141.22	40.9	102.81	456.24	97.27
Long-Term Leases	9.43	8.97	158.02	172.92	182.25	33.88
Pension & Post-Retirement Benefits	11.09	10.69	29.42	25.07	23.46	14.97
Long-Term Deferred Tax Liabilities	32.73	33.19	21.5	23.02	24	5.83
Other Long-Term Liabilities	1.2	2.16	2.29	1.79	0.01	2.61
Total Liabilities	475.05	523.2	1,078	1,261	1,265	698.73
Common Stock	2,020	2,020	1,717	1,538	1,538	2,120
Additional Paid-In Capital	-	-	-	59.43	59.43	-
Retained Earnings	-1,056	-1,078	-1,132	-810.61	-403.84	-1,028
Comprehensive Income & Other	-193.17	-193.17	-84.86	-49.19	-49.19	-177.68
Total Common Equity	770.04	748.53	500.34	737.83	1,145	914.1
Minority Interest	44.25	45.19	43.3	39.46	46.75	-28.08
Shareholders' Equity	814.29	793.72	543.63	777.28	1,191	886.03
Total Liabilities & Equity	1,289	1,317	1,621	2,039	2,457	1,585
Total Debt	216.57	243.62	614.14	819.66	921.92	323.17
Net Cash (Debt)	-107.42	-49.81	-533.52	-784.91	-668.57	-270.78
Net Cash Per Share	-0.14	-0.06	-0.86	-1.28	-1.11	-0.68
Filing Date Shares Outstanding	4,039	4,039	686.8	615.28	615.28	423.93
Total Common Shares Outstanding	4,039	4,039	686.8	615.28	615.28	423.93
Working Capital	113.85	72.98	-240.19	-300.97	302.56	296.27
Book Value Per Share	0.19	0.19	0.73	1.20	1.86	2.16
Tangible Book Value	342.3	317.95	196.77	428.92	642.21	831.3
Tangible Book Value Per Share	0.08	0.08	0.29	0.70	1.04	1.96
Land	-	56.34	94.65	93.68	93.68	68.66
Buildings	-	328.02	365.39	464.49	450.88	164.24
Machinery	-	477.96	541.77	861.78	908.65	640.66
Construction In Progress	-	1.19	4.08	7.91	12.97	150.21